Events Meeting on the Med

CGMOMed_logo_690x140 1

Meeting on the Med

Presentation: Which industry partner should I collaborate with? A scientists' journey to implementing an innovative technology

Apr 12 - Apr 14, 2023

Barcelona, Spain

Booth #3

Register for the conference

The American Society of Gene and Cell Therapy's (ASGCT) Annual Meeting, is the premier event for professionals in gene and cell therapy. It is the best place for people in the field to learn from the latest scientific research, stay up to date on new technologies, and make career-advancing connections with peers.

At MaxCyte, we take a collaborative approach with our clients to rapidly drive their developmental efforts from research forward to commercialization, safely, and cost-effectively. We partner with cutting-edge academic institutions, translational centers, and biopharmaceutical businesses by providing access to our scalable cell-engineering platform.

With our best-in-class delivery system, our team of scientific experts helps our collaborators unlock the potential of their products by solving development and commercialization challenges. This session will feature success stories from two of our client advocates, Dr. Jonathan Yen and Dr. Alicja Copik. Their talks will showcase MaxCyte's focus on high-performance cellular editing and our outstanding technical support to enable our customers to use a single unifying technology, from concept to clinic.

Presenter

Doerfler_Maxcyte

Dr. Jonathan Yen

Director of Therapeutic Genome Engineering (TGEn), St. Jude Children's Research Hospital

As the current Director of Therapeutic Genome Engineering at St. Jude's Children's Research Hospital, Dr. Johnathan Yen has been influential in utilizing our technology from process development to cGMP-manufacturing during his tenure.

Jessica-McClure-presentation 1

Dr. Alicja Copik

Associate Professor of Medicine at the Burnett School of Biomedical Sciences, UCF and Co-founder of Cyto-Sen Therapeutics, now Kiadis, a Sanofi company

Dr. Copik is an Associate Professor of Medicine and Core Scientist at the University of Central Florida. Her laboratory has developed a clinically relevant protocol for NK cell expansion that is simple, safe, economical, and effective, which can be applied in vitro or in vivo.

Popular resources

Conditional-Deletion-of-Large-DNA-Fragment-in-iPSCs-by-ssODN-Mediated-Insertion-of-LoxP-Sites-without-Antibiotic-Selection-b 1
Scientific Brief
Conditional Deletion of Large DNA Fragment in iPSCs by ssODN-Mediated Insertion of LoxP Sites without Antibiotic Selection
Conditional-Deletion-of-Large-DNA-Fragment-in-iPSCs-by-ssODN-Mediated-Insertion-of-LoxP-Sites-without-Antibiotic-Selection-Fig-2 1
Scientific Brief
Gene Editing: Paving the Way for Accelerated Clinical Development of Adoptive Cell Therapies
Experimental-Design-hires 1
Scientific Brief
Conditional Deletion of Large DNA Fragment in iPSCs by ssODN-Mediated Insertion of LoxP Sites without Antibiotic Selection
View All Resources